Diabetes & Metabolism

Comparative effectiveness of sodium-glucose cotransporter-2 versus dipeptidyl peptidase-4 inhibitors on all-cause mortality in type 2 diabetes: a multinational propensity score-matched cohort study

By Ching-Yu Li, Chih-Li Lin, Hung-Wen Cheng, Gwo-Ping Jong

Cohort study of 449,295 peopleInterventions

Independent replication, multicentre

The paper

Ching-Yu Li, Chih-Li Lin, Hung-Wen Cheng, Gwo-Ping Jong

Chung Shan Medical University Hospital

Diabetes & Metabolism, 4 Aug 2026

doi.org/10.1016/j.diabet.2026.101785 PubMed 42551692

Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes